181 related articles for article (PubMed ID: 25544029)
1. Applicability of the EORTC/MSG criteria for IFD in clinical practice.
Rieger H; Lustig D; Barlow S; Ostermann H; Fiegl M; Peterson L; Rieger CT
Ann Hematol; 2015 May; 94(5):847-55. PubMed ID: 25544029
[TBL] [Abstract][Full Text] [Related]
2. New category of probable invasive pulmonary aspergillosis in haematological patients.
Girmenia C; Guerrisi P; Frustaci AM; Fama A; Finolezzi E; Perrone S; Gentile G; Collerone F; Brocchieri S; Guerrisi V
Clin Microbiol Infect; 2012 Oct; 18(10):990-6. PubMed ID: 21999366
[TBL] [Abstract][Full Text] [Related]
3. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
[TBL] [Abstract][Full Text] [Related]
4. Triggers for driving treatment of at-risk patients with invasive fungal disease.
Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
[TBL] [Abstract][Full Text] [Related]
5. Classification of invasive fungal disease in patients with acute myeloid leukaemia.
Rieger CT; Huppmann S; Peterson L; Rieger H; Ostermann H
Mycoses; 2011 Jul; 54(4):e92-8. PubMed ID: 20202112
[TBL] [Abstract][Full Text] [Related]
6. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
[TBL] [Abstract][Full Text] [Related]
7. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
[TBL] [Abstract][Full Text] [Related]
8. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
9. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Dellow E; Herbrecht R; Donnelly JP
Mycoses; 2011 Sep; 54(5):e449-55. PubMed ID: 21039936
[TBL] [Abstract][Full Text] [Related]
10. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients.
Vehreschild MJ; von Bergwelt-Baildon M; Tran L; Shimabukuro-Vornhagen A; Wisplinghoff H; Bangard C; Cornely OA; Vehreschild JJ
Eur J Haematol; 2014 Nov; 93(5):400-6. PubMed ID: 24798021
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Borlenghi E; Cattaneo C; Capucci MA; Pan A; Quaresmini G; Franco F; Grazioli L; Carosi GP; Rossi G
Ann Hematol; 2007 Mar; 86(3):205-10. PubMed ID: 17119965
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
[TBL] [Abstract][Full Text] [Related]
14. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
16. Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy.
Acet-Öztürk NA; Ömer-Topçu D; Vurat-Acar K; Aydın-Güçlü Ö; Pınar İE; Demirdöğen E; Görek-Dilektaşlı A; Kazak E; Özkocaman V; Ursavas A; Akalın H; Özkalemkaş F; Ener B; Ali R
J Mycol Med; 2022 Nov; 32(4):101304. PubMed ID: 35738036
[TBL] [Abstract][Full Text] [Related]
17. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
[TBL] [Abstract][Full Text] [Related]
18. [Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Católica, Santiago-Chile using revised EORTC/MSG diagnostic criteria].
Rabagliati B R; Fuentes L G; Guzmán D AM; Orellana U E; Oporto C J; Aedo C I; Garrido S M; Nervi N B
Rev Chilena Infectol; 2009 Jun; 26(3):212-9. PubMed ID: 19621153
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China.
Zhang X; Hu J; Hu Y; Huang H; Jin J; Li J; Liu Q; Shao Z; Wang J; Wang Q; Wu D; Huang X
Clin Ther; 2017 Sep; 39(9):1758-1768. PubMed ID: 28756883
[TBL] [Abstract][Full Text] [Related]
20. Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience.
Castagnola E; Bagnasco F; Amoroso L; Caviglia I; Caruso S; Faraci M; Calvillo M; Moroni C; Bandettini R; Cangemi G; Magnano GM; Buffa P; Moscatelli A; Haupt R
Pediatr Infect Dis J; 2014 Mar; 33(3):233-7. PubMed ID: 24136371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
